相关实验视频
Updated: Jul 12, 2025

08:16
Movement Retraining using Real-time Feedback of Performance
Published on: January 17, 2013
13.4K
功能性运动障碍的物理治疗管理:患者的角度
1Department of Physiotherapy, School of Health Professions, University of Plymouth, Plymouth, UK.
Disability and rehabilitation
|October 25, 2023
概括
功能性运动障碍 (FMD) 患者寻求整体物理治疗,结合心理和身体方法. 经验丰富的物理治疗师的个性化护理是关键,但有限的专业治疗机会会阻碍康复.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 精神病体医学是一种精神病体医学.
背景情况:
- 功能性运动障碍 (FMD) 在神经病诊所中很普遍.
- 英国缺乏针对口热的标准化治疗途径.
- 有限的定性研究对口病理疗法的感知是可用的.
研究的目的:
- 探索患者对功能运动障碍 (FMD) 物理治疗治疗的看法.
- 确定影响口病理疗法的有效性的关键主题.
- 为改进口病管理策略的制定提供信息.
主要方法:
- 进行了基于网络的定性采访,对7名口病患者进行了采访.
- 用解释性现象学分析来分析采访数据.
- 这项研究的重点是了解患者对物理治疗的体验.
主要成果:
- 出现了四个主要主题:整体的心身联系,物理治疗的有效性,个人恢复定义和治疗障碍.
- 参与者更喜欢综合心理和物理疗法,根据他们的需要进行个性化治疗.
- 障碍包括专业口炎治疗的有限可用性和资金.
结论:
- 综合心理和生理方法的整体管理对于口病至关重要.
- 由经验丰富的临床医生提供的个性化,以患者为中心的物理治疗改善了结果.
- 加强医疗保健专业人员的理解可以促进及时,适当的口病患者途径.
更多相关视频
06:28Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
Published on: December 13, 2024
546
05:28Author Spotlight: Enhancing Upper Limb Rehabilitation in Stroke Patients Through Advanced Robotic and Neuromodulation Technologies
Published on: October 11, 2024
613
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Parkinson's Disease: Overview
567
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
567